Investing Profile

Nanna Luneborg

InvestorVC
General Partner at Forbion
forbion.comDenmark
Photo of Nanna Luneborg, General Partner at Forbion
Your Intro Paths to Nanna Luneborg

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Nanna Luneborg on

cb
Current Investing Position
Forbion General Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
11

Nanna Luneborg is on these Sector & Stage Rankings

Nanna Luneborg's Investments On Record (9)

CompanyStageDateRound SizeTotal Raised
Capstan Therapeutics
Series BMar 2024$180M
$280M
Co-investors: Michael Baran (Pfizer Venture Investments)
Noema Pharma
Series BMar 2023$110M
$110M
Co-investors: Antoine Papiernik Papiernik (Soffinova Partners)
Inversago Pharma
Series COct 2022$69M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Elizabeth Douville (Amorchem), Marco Boorsma (Forbion)
F2G
Private EquityAug 2022$70M
$160M
Co-investors: Maha Katabi (Sofinnova Investments), Anja Konig (Novartis Venture Fund), Raj Parekh (Advent Life Sciences), Joseph Anderson (Soffinova Partners)
Numab
Series CMay 2021$110M
$110M
Lava Therapeutics
Series CSep 2020$83M
$100M
Co-investors: Guido Magni (Versant Ventures), Joël Jean-Mairet (Ysios Capital), Laia Crespo (Sanofi Ventures)
NodThera
Series BJun 2020$55M
$95M
Co-investors: Scott Rocklage (5am Ventures), Alexander Pasteur (F-Prime Capital Partners), Henrijette Richter (Soffinova Partners)
NBE-Therapeutics
Series BJun 2018$20M
$20M